Skip to content

Lexicon Pharmaceuticals LXRX Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Cytokinetics logo
CytokineticsCYTK
$18.47M+45.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$143K-51.2%
Mannkind logo
MannkindMNKD
$22.02M-21.5%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$54K+350%
Opko Health logo
Opko HealthOPK
$18.9M+0.7%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
Enterprise value$976.73M+209%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's other non-current assets?
Lexicon Pharmaceuticals (LXRX) reported other non-current assets of $368K in Q1 2026.
How has Lexicon Pharmaceuticals's other non-current assets changed year-over-year?
Lexicon Pharmaceuticals's other non-current assets decreased by 0.0% year-over-year, from $368K to $368K.
What is the long-term trend for Lexicon Pharmaceuticals's other non-current assets?
Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's other non-current assets has grown at a -21.5% compound annual growth rate (CAGR), from $1.23M to $368K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.